Evidence map›Paper›PMID 32146482›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Derivation and Validation of a Novel Severity Scoring System for Pneumonia at Intensive Care Unit Admission.

Thomas A Carmo, Isabella B Ferreira, Rodrigo C Menezes, Gabriel P Telles, Matheus L Otero, Maria B Arriaga, Kiyoshi F Fukutani, Licurgo P Neto, Sydney Agareno, Nivaldo M Filgueiras Filho and 2 more

Abstract readValidation Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. A rapid surveillance of pneumonia in hospitalized patients: an opportunity for intervention.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Top-ten papers in pneumonia (2020-2021).Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Review
  18. Article
  19. Article
  20. Scores to Predict Long-term Mortality in Patients With Severe Pneumonia Still Lacking.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Thomas A CarmoUniversidade Salvador, Salvador, Bahia, Brazil.
Isabella B FerreiraUniversidade do Estado da Bahia, Salvador, Bahia, Brazil.
Rodrigo C MenezesUnião Metropolitana para o Desenvolvimento da Educação e Cultura, Salvador, Bahia, Brazil.
Gabriel P TellesEscola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil.
Matheus L OteroUniversidade Salvador, Salvador, Bahia, Brazil.
Maria B ArriagaMultinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Fundação José Silveira, Salvador, Brazil.
Kiyoshi F FukutaniMultinational Organization Network Sponsoring Translational and Epidemiological Research Initiative, Fundação José Silveira, Salvador, Brazil.
Licurgo P NetoHospital de Cidade, Intensive Care Unit, Salvador, Bahia, Brazil.
Sydney AgarenoHospital de Cidade, Intensive Care Unit, Salvador, Bahia, Brazil.
Nivaldo M Filgueiras FilhoUniversidade Salvador, Salvador, Bahia, Brazil.
Bruno B AndradeUniversidade Salvador, Salvador, Bahia, Brazil.
Kevan M AkramiInstituto Gonçalo Moniz, Fiocruz, Salvador, Bahia, Brazil.

Funding

Inflammatory determinants of disease severity and treatment outcome in TB patientsU01AI115940 · NIAID · UNIVERSITY OF CAPE TOWN · PI SHER, ALAN, WILKINSON, ROBERT JOHN · 2015 to 2019
$1.1M
NIAID NIH HHS U01 AI115940
6 · The paper itself

Abstract

backgroundSeverity stratification scores developed in intensive care units (ICUs) are used in interventional studies to identify the most critically ill. Studies that evaluate accuracy of these scores in ICU patients admitted with pneumonia are lacking. This study aims to determine performance of severity scores as predictors of mortality in critically ill patients admitted with pneumonia.

methodsProspective cohort study in a general ICU in Brazil. ICU severity scores (Simplified Acute Physiology Score 3 [SAPS 3] and Sepsis-Related Organ Failure Assessment [qSOFA]), prognostic scores of pneumonia (CURB-65 [confusion, urea, respiratory rate, blood pressure, age] and CRB-65 [confusion, respiratory rate, blood pressure, age]), and clinical and epidemiological variables in the first 6 hours of hospitalization were analyzed.

resultsTwo hundred patients were included between 2015 and 2018, with a median age of 81 years (interquartile range, 67-90 years) and female predominance (52%), primarily admitted from the emergency department (65%) with community-acquired pneumonia (CAP, 80.5%). SAPS 3, CURB-65, CRB-65,and qSOFA all exhibited poor performance in predicting mortality. Multivariate regression identified variables independently associated with mortality that were used to develop a novel pneumonia-specific ICU severity score (Pneumonia Shock score) that outperformed SAPS 3, CURB-65, and CRB-65. The Shock score was validated in an external multicenter cohort of critically ill patients admitted with CAP.

conclusionsWe created a parsimonious score that accurately identifies patients with pneumonia at highest risk of ICU death. These findings are critical to accurately stratify patients with severe pneumonia in therapeutic trials that aim to reduce mortality.

Indexed as

Community-Acquired InfectionsIntensive Care UnitsPneumoniaAgedAged, 80 and overBrazilFemaleHospitalizationHospital MortalityHumansMalePrognosisProspective StudiesRetrospective StudiesSeverity of Illness Indexintensive care unitmortalitypneumoniaseverity scores

Identifiers

PMID32146482
PMCPMC7958772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.